According to the announcement of Huafeng Co., Ltd., the closing price of the company's stock fell by more than 20% for three consecutive trading days on October 30, November 2, and November 3, 2026, which is an abnormal fluctuation in stock trading. After self-inspection and verification with the controlling shareholder and actual controller, as of the date of disclosure of the announcement, there was no material information that should have been disclosed but not disclosed, other than matters already disclosed. The company's current production and operation activities are normal. There have been no major adjustments in the market environment or industry policies, the internal business order is normal, no media reports or market rumors involving hot concepts or affecting stock prices have been discovered, and directors, supervisors, controlling shareholders, and actual controllers have not traded the company's shares during the period of change. Investors are kindly requested to pay attention to investment risks.

According to the announcement of Huafeng Co., Ltd., the closing price of the company's stock fell by more than 20% for three consecutive trading days on October 30, November 2, and November 3, 2026, which is an abnormal fluctuation in stock trading. After self-inspection and verification with the controlling shareholder and actual controller, as of the date of disclosure of the announcement, there was no material information that should have been disclosed but not disclosed, other than matters already disclosed. The company's current production and operation activities are normal. There have been no major adjustments in the market environment or industry policies, the internal business order is normal, no media reports or market rumors involving hot concepts or affecting stock prices have been discovered, and directors, supervisors, controlling shareholders, and actual controllers have not traded the company's shares during the period of change. Investors are kindly requested to pay attention to investment risks.